作者
Vítor Mendes Pereira,Jan Gralla,Antoni Dávalos,Alain Bonafé,Carlos Castaño,René Chapot,David S. Liebeskind,Raul G Nogueira,Marcel Arnold,Roman Sztajzel,Thomas Liebig,Mayank Goyal,Michael Besselmann,Antonio Moreno,Gerhard Schroth,S. Alamovitch,Caroline Arquizan,Christian Dohmen,Monika Killer‐Oberpfalzer,Erasmia Broussalis,Lars Udo Krause,L. López‐Ibor,Juan Macho,Sergio Amaro,Bijoy K. Menon,Martínez Millán,Ferdinand Miteff,Kenneth Faulder,Michel Piotin,Ralph Weber,G. Parrilla
摘要
Background and Purpose— Mechanical thrombectomy using stent retriever devices have been advocated to increase revascularization in intracranial vessel occlusion. We present the results of a large prospective study on the use of the Solitaire Flow Restoration in patients with acute ischemic stroke. Methods— Solitaire Flow Restoration Thrombectomy for Acute Revascularization was an international, multicenter, prospective, single-arm study of Solitaire Flow Restoration thrombectomy in patients with large vessel anterior circulation strokes treated within 8 hours of symptom onset. Strict criteria for site selection were applied. The primary end point was the revascularization rate (thrombolysis in cerebral infarction ≥2b) of the occluded vessel as determined by an independent core laboratory. The secondary end point was the rate of good functional outcome (defined as 90-day modified Rankin scale, 0–2). Results— A total of 202 patients were enrolled across 14 comprehensive stroke centers in Europe, Canada, and Australia. The median age was 72 years, 60% were female patients. The median National Institute of Health Stroke Scale was 17. Most proximal intracranial occlusion was the internal carotid artery in 18%, and the middle cerebral artery in 82%. Successful revascularization was achieved in 79.2% of patients. Device and procedure-related severe adverse events were found in 7.4%. Favorable neurological outcome was found in 57.9%. The mortality rate was 6.9%. Any intracranial hemorrhagic transformation was found in 18.8% of patients, 1.5% were symptomatic. Conclusions— In this single-arm study, treatment with the Solitaire Flow Restoration device in intracranial anterior circulation occlusions results in high rates of revascularization, low risk of clinically relevant procedural complications, and good clinical outcomes in combination with low mortality at 90 days. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT01327989.